
Abbott agrees to consent decree with FDA, could restart plant within 2 weeks, pending court approval
CNN
The baby formula manufacturer at the heart of a nationwide formula recall says it has reached an agreement with the US Food and Drug Administration to enter into a consent decree, a legally binding agreement that would require the company to take certain steps in response to violations found at its Sturgis, Michigan, facility.
If a court approves the agreement, the company says it could restart the site within two weeks. It would first resume the production of its specialty metabolic formulas EleCare and Alimentum, followed by Similac and other formulas.
After Abbott restarts the site, it will take six to eight weeks for the products to reach store shelves, it said.

The White House is making clear it views President Donald Trump’s Friday Oval Office showdown with Ukrainian President Volodymyr Zelensky as an overwhelming win underscoring Trump’s “America First” leadership, dispatching top officials and allies on the airwaves to amplify Trump’s handling of the situation even as European leaders are putting on a key show of force of unity for Ukraine and its leader.